Study shows more women with invasive lobular breast cancer should qualify for tailored clinical trials 30 Mar 2022 A new study led by scientists at The Institute of Cancer Research, London, has changed our understanding of invasive lobular breast cancer – and could increase the number of patients who access new treatments via lobular breast cancer specific clinical trials. Find out more Show/Hide